Mark Greenwood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mark Greenwood has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Ronald K. June
Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, USA
3 shared publications - Bibiana Bielekova
Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
2 shared publications - Prasanta Sankar Bandyopadhyay
Department of History and Philosophy, Montana State University, Bozeman, MT 59717, USA
2 shared publications - Tan Tran
Statistical and Consulting Research Services, Montana State University, Bozeman, MT 59718, USA
2 shared publications Aidan J. Gregory
1 shared publication- Alan S. L. Yu
University of Kansas Medical Center
1 shared publication
Latest Publications
- 4 November 2026
- Published by The R Foundation
F2Adonis2: PERMANOVA using the F2 Statistic
Implements the F2 statistic of Anderson et al. (2017) for permutational multivariate analysis of variance (PERMANOVA) on dissimilarity matrices. The F2 statistic uses group-specific dispersion estimates, so group centroids can be compared when dispersions differ and group sizes are unequal. P-values are obtained by permutation, bootstrap, or bias-adjusted bootstrap. The formula interface follows 'adonis2()' in the 'vegan' package.
- 4 November 2026
- Published by The R Foundation
F2Adonis2: PERMANOVA using the F2 Statistic
Implements the F2 statistic of Anderson et al. (2017) for permutational multivariate analysis of variance (PERMANOVA) on dissimilarity matrices. The F2 statistic uses group-specific dispersion estimates, so group centroids can be compared when dispersions differ and group sizes are unequal. P-values are obtained by permutation, bootstrap, or bias-adjusted bootstrap. The formula interface follows 'adonis2()' in the 'vegan' package.
- Open Access
- 3 October 2025
- Published by Wiley in Annals of Neurology
- Vol. 99 (2) , 328-340
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis
Objective: The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiplex proteomic technologies suggest that cerebrospinal fluid (CSF) analysis at MS onset may not only improve diagnostic accuracy, but also offer prognostic and staging information, as well as insight into molecular therapeutic targets. Methods: This multicenter study retrospectively analyzed cryopreserved CSF samples from 160 individuals undergoing diagnostic evaluation for possible neuroimmunological disorder, and among these, followed a cohort of 96 people with confirmed MS for at least 3 years. The goal was to externally validate previously published CSF‐based diagnostic and prognostic classifiers. Results: Upon unblinding, the CSF‐based molecular diagnostic test distinguished 96 people with confirmed MS from 30 individuals with other inflammatory neurological diseases, and 34 individuals with non‐inflammatory neurological diseases, achieving an area under the receiver operating characteristic curve of 0.94 ( p = 4.7 × 10 −21 ). The test also differentiated 65 individuals with relapsing–remitting MS from 31 individuals with progressive MS, with an area under the receiver operating characteristic curve of 0.76 ( p = 1.4 × 10 −5 ). The prognostic classifier predicted prospectively measured Expanded Disability Status Scale scores at follow up (rho = 0.43, p = 2.54 × 10 −5 ). Interpretation: This multicenter external validation study demonstrates that CSF‐based molecular tests can robustly distinguish MS from other neurological conditions, stratify MS subtypes, and predict future disability progression in real‐world settings. These results lay the groundwork for development of next‐generation molecular tools to personalize care in MS. ANN NEUROL 2026;99:328–340
- 3 October 2025
- Published by Wiley in Annals of Neurology
- Vol. 99 (2) , 328-340
Open AccessFrom Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis
Objective: The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiplex proteomic technologies suggest that cerebrospinal fluid (CSF) analysis at MS onset may not only improve diagnostic accuracy, but also offer prognostic and staging information, as well as insight into molecular therapeutic targets. Methods: This multicenter study retrospectively analyzed cryopreserved CSF samples from 160 individuals undergoing diagnostic evaluation for possible neuroimmunological disorder, and among these, followed a cohort of 96 people with confirmed MS for at least 3 years. The goal was to externally validate previously published CSF‐based diagnostic and prognostic classifiers. Results: Upon unblinding, the CSF‐based molecular diagnostic test distinguished 96 people with confirmed MS from 30 individuals with other inflammatory neurological diseases, and 34 individuals with non‐inflammatory neurological diseases, achieving an area under the receiver operating characteristic curve of 0.94 ( p = 4.7 × 10 −21 ). The test also differentiated 65 individuals with relapsing–remitting MS from 31 individuals with progressive MS, with an area under the receiver operating characteristic curve of 0.76 ( p = 1.4 × 10 −5 ). The prognostic classifier predicted prospectively measured Expanded Disability Status Scale scores at follow up (rho = 0.43, p = 2.54 × 10 −5 ). Interpretation: This multicenter external validation study demonstrates that CSF‐based molecular tests can robustly distinguish MS from other neurological conditions, stratify MS subtypes, and predict future disability progression in real‐world settings. These results lay the groundwork for development of next‐generation molecular tools to personalize care in MS. ANN NEUROL 2026;99:328–340
- 1 June 2023
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 324 (6) , F590-F602
Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease
To our knowledge, this study is the first to generate urinary global metabolomic profiles from individuals with early-stage ADPKD with preserved renal function for biomarker discovery. The exploratory dataset reveals metabolic pathway alterations that may be responsible for early cystogenesis and rapid disease progression and may be potential therapeutic targets and pathway sources for candidate biomarkers. From these results, we generated a panel of candidate diagnostic and prognostic biomarkers of early-stage ADPKD for future validation.
- 1 June 2023
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 324 (6) , F590-F602
Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease
To our knowledge, this study is the first to generate urinary global metabolomic profiles from individuals with early-stage ADPKD with preserved renal function for biomarker discovery. The exploratory dataset reveals metabolic pathway alterations that may be responsible for early cystogenesis and rapid disease progression and may be potential therapeutic targets and pathway sources for candidate biomarkers. From these results, we generated a panel of candidate diagnostic and prognostic biomarkers of early-stage ADPKD for future validation.
- Open Access
Does Elevated [CO2] Only Increase Root Growth in the Topsoil? A FACE Study with Lentil in a Semi-Arid Environment
Atmospheric carbon dioxide concentrations [CO2] are increasing steadily. Some reports have shown that root growth in grain crops is mostly stimulated in the topsoil rather than evenly throughout the soil profile by e[CO2], which is not optimal for crops grown in semi-arid environments with strong reliance on stored water. An experiment was conducted during the 2014 and 2015 growing seasons with two lentil (Lens culinaris) genotypes grown under Free Air CO2 Enrichment (FACE) in which root growth was observed non-destructively with mini-rhizotrons approximately every 2–3 weeks. Root growth was not always statistically increased by e[CO2] and not consistently between depths and genotypes. In 2014, root growth in the top 15 cm of the soil profile (topsoil) was indeed increased by e[CO2], but increases at lower depths (30–45 cm) later in the season were greater than in the topsoil. In 2015, e[CO2] only increased root length in the topsoil for one genotype, potentially reflecting the lack of plant available soil water between 30–60 cm until recharged by irrigation during grain filling. Our limited data to compare responses to e[CO2] showed that root length increases in the topsoil were correlated with a lower yield response to e[CO2]. The increase in yield response was rather correlated with increases in root growth below 30 cm depth.
Open AccessDoes Elevated [CO2] Only Increase Root Growth in the Topsoil? A FACE Study with Lentil in a Semi-Arid Environment
Atmospheric carbon dioxide concentrations [CO2] are increasing steadily. Some reports have shown that root growth in grain crops is mostly stimulated in the topsoil rather than evenly throughout the soil profile by e[CO2], which is not optimal for crops grown in semi-arid environments with strong reliance on stored water. An experiment was conducted during the 2014 and 2015 growing seasons with two lentil (Lens culinaris) genotypes grown under Free Air CO2 Enrichment (FACE) in which root growth was observed non-destructively with mini-rhizotrons approximately every 2–3 weeks. Root growth was not always statistically increased by e[CO2] and not consistently between depths and genotypes. In 2014, root growth in the top 15 cm of the soil profile (topsoil) was indeed increased by e[CO2], but increases at lower depths (30–45 cm) later in the season were greater than in the topsoil. In 2015, e[CO2] only increased root length in the topsoil for one genotype, potentially reflecting the lack of plant available soil water between 30–60 cm until recharged by irrigation during grain filling. Our limited data to compare responses to e[CO2] showed that root length increases in the topsoil were correlated with a lower yield response to e[CO2]. The increase in yield response was rather correlated with increases in root growth below 30 cm depth.
- Open Access
- 1 January 2021
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 77 (Suppl. 4) , 30-32
Estimating Differences in Risk of Chronic Kidney Disease Based on Water Intake in a National Sample
Background: In agricultural communities in Central and South America, Egypt, India, and Sri Lanka, an unexplained form of chronic kidney disease affects agricultural workers. Termed chronic kidney disease of unknown origin (CKDu), it disproportionately affects young men in their 30s–40s and is unrelated to the traditional risk factors of diabetes, hypertension, and obesity [1–3]. Recent investigations suggest that agricultural work in the USA carries similar risks, as reduced kidney function has been found among those working in US agriculture [4–5]. However, researchers are yet to determine the etiology of the disease [6–8]. Central to the hypotheses of CKDu is the reduced blood flow to the kidneys due to inadequate hydration during periods of intense physical labor. Objectives: The primary aim of the current investigation was to identify if a relationship between hydration and kidney function exists among the general population by using the data from the National Health and Nutrition Examination Survey (NHANES). We hypothesize that reduced hydration will be associated with reduced kidney function. Methods: Data were retrieved from the NHANES dataset from 3 sample years 2005/2006, 2007/2008, and 2011/2012. Data were merged across all 3 periods with survey weights adjusted for combining across multiple years. Participants were excluded if they had missing data for hydration or kidney function, or if they were Results: Of the 13,056 participants initially sampled, 10,651 participants are included in the analysis after cleaning and including survey weights. 9,125 (85.67%) of participants were in the low-risk group, 1,128 (10.59%) were classified as medium-risk, while the remaining 398 (3.74%) were high risk (Fig. 1). Adjusting for survey weights, results suggest that the estimated rate of high-risk kidney function was 5% more for low water drinkers compared to high water drinkers (Fig. 2). There is strong evidence of a difference in CKD risk categories based on TWI (χ2(1) = 13.1, p value 2(1) = 3.3, p value = 0.067). Conclusions: Not meeting recommended daily TWI was associated increased presentation of high-risk kidney function. Even though the NHANES data are not focused on areas where chronic kidney disease is prevalent, results from this are an indication that hydration does play a role in kidney function.
- 1 January 2021
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 77 (Suppl. 4) , 30-32
Open AccessEstimating Differences in Risk of Chronic Kidney Disease Based on Water Intake in a National Sample
Background: In agricultural communities in Central and South America, Egypt, India, and Sri Lanka, an unexplained form of chronic kidney disease affects agricultural workers. Termed chronic kidney disease of unknown origin (CKDu), it disproportionately affects young men in their 30s–40s and is unrelated to the traditional risk factors of diabetes, hypertension, and obesity [1–3]. Recent investigations suggest that agricultural work in the USA carries similar risks, as reduced kidney function has been found among those working in US agriculture [4–5]. However, researchers are yet to determine the etiology of the disease [6–8]. Central to the hypotheses of CKDu is the reduced blood flow to the kidneys due to inadequate hydration during periods of intense physical labor. Objectives: The primary aim of the current investigation was to identify if a relationship between hydration and kidney function exists among the general population by using the data from the National Health and Nutrition Examination Survey (NHANES). We hypothesize that reduced hydration will be associated with reduced kidney function. Methods: Data were retrieved from the NHANES dataset from 3 sample years 2005/2006, 2007/2008, and 2011/2012. Data were merged across all 3 periods with survey weights adjusted for combining across multiple years. Participants were excluded if they had missing data for hydration or kidney function, or if they were Results: Of the 13,056 participants initially sampled, 10,651 participants are included in the analysis after cleaning and including survey weights. 9,125 (85.67%) of participants were in the low-risk group, 1,128 (10.59%) were classified as medium-risk, while the remaining 398 (3.74%) were high risk (Fig. 1). Adjusting for survey weights, results suggest that the estimated rate of high-risk kidney function was 5% more for low water drinkers compared to high water drinkers (Fig. 2). There is strong evidence of a difference in CKD risk categories based on TWI (χ2(1) = 13.1, p value 2(1) = 3.3, p value = 0.067). Conclusions: Not meeting recommended daily TWI was associated increased presentation of high-risk kidney function. Even though the NHANES data are not focused on areas where chronic kidney disease is prevalent, results from this are an indication that hydration does play a role in kidney function.
- Open Access
Are Scientific Models of Life Testable? A Lesson from Simpson’s Paradox
We address the need for a model by considering two competing theories regarding the origin of life: (i) the Metabolism First theory, and (ii) the RNA World theory. We discuss two interrelated points, namely: (i) Models are valuable tools for understanding both the processes and intricacies of origin-of-life issues, and (ii) Insights from models also help us to evaluate the core objection to origin-of-life theories, called “the inefficiency objection”, which is commonly raised by proponents of both the Metabolism First theory and the RNA World theory against each other. We use Simpson’s Paradox (SP) as a tool for challenging this objection. We will use models in various senses, ranging from taking them as representations of reality to treating them as theories/accounts that provide heuristics for probing reality. In this paper, we will frequently use models and theories interchangeably. Additionally, we investigate Conway’s Game of Life and contrast it with our SP-based approach to emergence-of-life issues. Finally, we discuss some of the consequences of our view. A scientific model is testable in three senses: (i) a logical sense, (ii) a nomological sense, and (iii) a current technological sense. The SP-based model is testable in the first two senses but it is not feasible to test it using current technology.
Open AccessAre Scientific Models of Life Testable? A Lesson from Simpson’s Paradox
We address the need for a model by considering two competing theories regarding the origin of life: (i) the Metabolism First theory, and (ii) the RNA World theory. We discuss two interrelated points, namely: (i) Models are valuable tools for understanding both the processes and intricacies of origin-of-life issues, and (ii) Insights from models also help us to evaluate the core objection to origin-of-life theories, called “the inefficiency objection”, which is commonly raised by proponents of both the Metabolism First theory and the RNA World theory against each other. We use Simpson’s Paradox (SP) as a tool for challenging this objection. We will use models in various senses, ranging from taking them as representations of reality to treating them as theories/accounts that provide heuristics for probing reality. In this paper, we will frequently use models and theories interchangeably. Additionally, we investigate Conway’s Game of Life and contrast it with our SP-based approach to emergence-of-life issues. Finally, we discuss some of the consequences of our view. A scientific model is testable in three senses: (i) a logical sense, (ii) a nomological sense, and (iii) a current technological sense. The SP-based model is testable in the first two senses but it is not feasible to test it using current technology.
- 2 December 2020
- Published by The R Foundation
puls: Partitioning Using Local Subregions
- 6 November 2020
- Published by The R Foundation
monoClust: Perform Monothetic Clustering with Extensions to Circular Data
- 6 November 2020
- Published by The R Foundation
monoClust: Perform Monothetic Clustering with Extensions to Circular Data
- Open Access
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
The inability to measure putative pathogenic processes in the central nervous system (CNS) of living subjects precludes the determination of their temporal distribution, intra-individual heterogeneity, and their ability to predict disease course. Using multiple sclerosis (MS) as an example of a complex neurological disorder, we sought to determine if cerebrospinal fluid (CSF) biomarkers can be aggregated to predict future rates of MS progression and provide molecular insight into mechanisms of CNS destruction. 1,305 CSF biomarkers were analyzed blindly in the longitudinal training dataset (N=129) of untreated MS patients, using DNA-aptamer assay. Random forest models, validated in an independent longitudinal cohort (N=64), uncovered signatures of MS severity, measured by clinical scales and volumetric brain imaging. Cluster analysis revealed intra-individual molecular heterogeneity of disease mechanisms that include both CNS- and immune-related pathways and may represent novel targets for inhibiting MS progression.
Open AccessMolecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
The inability to measure putative pathogenic processes in the central nervous system (CNS) of living subjects precludes the determination of their temporal distribution, intra-individual heterogeneity, and their ability to predict disease course. Using multiple sclerosis (MS) as an example of a complex neurological disorder, we sought to determine if cerebrospinal fluid (CSF) biomarkers can be aggregated to predict future rates of MS progression and provide molecular insight into mechanisms of CNS destruction. 1,305 CSF biomarkers were analyzed blindly in the longitudinal training dataset (N=129) of untreated MS patients, using DNA-aptamer assay. Random forest models, validated in an independent longitudinal cohort (N=64), uncovered signatures of MS severity, measured by clinical scales and volumetric brain imaging. Cluster analysis revealed intra-individual molecular heterogeneity of disease mechanisms that include both CNS- and immune-related pathways and may represent novel targets for inhibiting MS progression.